Advertisement
U.S. Markets close in 40 mins

Fennec Pharmaceuticals Inc. (FENC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
4.0750+0.0850 (+2.13%)
As of 03:14PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close3.9900
Open4.0400
Bid4.0300 x 100
Ask4.1200 x 100
Day's Range4.0100 - 4.1100
52 Week Range3.9600 - 11.9200
Volume39,888
Avg. Volume93,493
Market Cap112.566M
Beta (5Y Monthly)0.27
PE Ratio (TTM)N/A
EPS (TTM)-0.0400
Earnings DateNov 07, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.60
  • GlobeNewswire

    Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

    RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will be participating in the 15th Annual Craig-Hallum Alpha Select Conference. The Company's management will be available for one-on-one meetings throughout the event. Conference Details: Event: 15th Annual Craig-Hallum Alpha Select ConferenceDate: November 19, 2024Location: Sheraton New York Tim

  • Simply Wall St.

    Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations

    Fennec Pharmaceuticals ( NASDAQ:FENC ) Third Quarter 2024 Results Key Financial Results Revenue: US$6.97m (up 7.0% from...